TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36475816

Group type: EXPERIMENTAL
Intervention: Lipiodol‐bleomycin emulsion and NBCA‐Lipiodol emulsion
Number of subjects: 72

Group type: COMPARATOR
Intervention: PVA
Number of subjects: 72
Study: 33883199

Group type: EXPERIMENTAL
Intervention: Personalised information about spirometry results (Intervention Group - IG)
Number of subjects: 571

Group type: COMPARATOR
Intervention: Brief smoking cessation advice (Control Group - CG)
Number of subjects: 571

Group type: EXPERIMENTAL
Intervention: Cumulative abstinence curve (Intervention Group - IG)
Number of subjects: 571
Study: 32564674

Group type: EXPERIMENTAL
Intervention: Knowledge of result (KR) during vertical jump testing
Number of subjects: 16

Group type: COMPARATOR
Intervention: No knowledge of result (without KR) during vertical jump testing
Number of subjects: 16
Study: 34192421

Group type: EXPERIMENTAL
Intervention: Visual abstracts
Number of subjects: 307

Group type: COMPARATOR
Intervention: Control group (no visual abstracts)
Number of subjects: 307
Study: 32048396

Group type: EXPERIMENTAL
Intervention: vildagliptin 50 mg/day in addition to insulin
Number of subjects: 65

Group type: COMPARATOR
Intervention: insulin-only group
Number of subjects: 65
Study: 35227407

Group type: EXPERIMENTAL
Intervention: Cognitive Rehearsal
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Memory Substitution
Number of subjects: 88
Study: 32232364

Group type: EXPERIMENTAL
Intervention: Public hospitals
Number of subjects: 873

Group type: EXPERIMENTAL
Intervention: Health centers
Number of subjects: 873

Group type: EXPERIMENTAL
Intervention: Private facilities
Number of subjects: 873

Group type: EXPERIMENTAL
Intervention: Urban facilities
Number of subjects: 873

Group type: EXPERIMENTAL
Intervention: Rural facilities
Number of subjects: 873

Group type: COMPARATOR
Intervention: Health centers vs. hospitals
Number of subjects: 873

Group type: COMPARATOR
Intervention: Private facilities vs. hospitals
Number of subjects: 873

Group type: EXPERIMENTAL
Intervention: Regions
Number of subjects: 873
Study: 33131909

Group type: EXPERIMENTAL
Intervention: Duodenal-jejunal bypass liner (DJBL) for 12 months
Number of subjects: 70

Group type: COMPARATOR
Intervention: Best medical therapy, diet and exercise
Number of subjects: 70
Study: 32794487

Group type: EXPERIMENTAL
Intervention: Proanthocyanidin (6.5%)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Genipin (6.5%)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Glutaraldehyde (6.5%)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control (no primer application)
Number of subjects: 80
Study: 35907471

Group type: EXPERIMENTAL
Intervention: Preference music (PM)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Non-preference music (nPM)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Without music (WM)
Number of subjects: 11
Study: 33559245

Group type: EXPERIMENTAL
Intervention: Magnesium (200 mg) combined with 2 ml bupivacaine and 1 ml (40 mg) methylprednisolone
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (2 ml bupivacaine, 1 ml (40 mg) methylprednisolone and 1 ml saline (0.9%))
Number of subjects: 50
Study: 32162821

Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy (SBRT) of 16 Gy in 1 fraction
Number of subjects: 10

Group type: COMPARATOR
Intervention: Decompression surgery followed by fractionated radiotherapy of 30 Gy in 10 fractions
Number of subjects: 10
Study: 34037911

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (200mg BID)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 51
Study: 33369824

Group type: EXPERIMENTAL
Intervention: Analgesic treatment and MET (Medical Expulsive Therapy)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Surgical intervention
Number of subjects: 14
Study: 34297066

Group type: EXPERIMENTAL
Intervention: Adipose tissue-derived stromal vascular fraction (AD-SVF) injection
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (lactated Ringer's solution)
Number of subjects: 40
Study: 34682824

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid/trehalose ophthalmic solution (Thealoz® Duo) three times/day in the preoperative week and for 5 postoperative weeks (Group A)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid/trehalose ophthalmic solution (Thealoz® Duo) for only 5 postoperative weeks (Group B)
Number of subjects: 120

Group type: COMPARATOR
Intervention: No artificial tears (Group C)
Number of subjects: 120
Study: 36192800

Group type: EXPERIMENTAL
Intervention: Nordic walking intervention (two sessions per week for twelve weeks)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Nordic walking plus socio-ecological approach (two sessions per week for twelve weeks)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Usual healthcare professionals’ walking advice on physical activity (control group)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 144
Study: 34006266

Group type: EXPERIMENTAL
Intervention: Adaptation of WHO PEN/HEARTS clinical algorithms, two-day training of doctors and nurses, supportive supervision visits, clinical decision support tools, quality improvement support.
Number of subjects: 1085

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 1085

Group type: EXPERIMENTAL
Intervention: Intervention clinics (relative to control).
Number of subjects: 1085

Group type: COMPARATOR
Intervention: Control clinics (relative to intervention).
Number of subjects: 1085
Study: 32205595

Group type: EXPERIMENTAL
Intervention: Early and progressive mobility program with five levels of activity
Number of subjects: 99

Group type: COMPARATOR
Intervention: Conventional treatment without a preestablished routine
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Early and progressive mobility program
Number of subjects: 99
Study: 36065580

Group type: EXPERIMENTAL
Intervention: Cognitive Remediation Therapy (CRT) added to IPS
Number of subjects: 97

Group type: COMPARATOR
Intervention: IPS alone
Number of subjects: 97
Study: 33960404

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 32827344

Group type: EXPERIMENTAL
Intervention: Automated oxygen administration using the FreeO2 device
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional manual oxygen administration
Number of subjects: 60
Study: 32047601

Group type: EXPERIMENTAL
Intervention: Multiple visit endodontic treatment with triple antibiotic paste interappointment dressing
Number of subjects: 44

Group type: COMPARATOR
Intervention: Single visit endodontic treatment without interappointment dressing
Number of subjects: 44
Study: 34032760

Group type: EXPERIMENTAL
Intervention: Early Mobilization (EM) protocol
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard Early Rehabilitation (SER) protocol
Number of subjects: 60
Study: 33152035

Group type: EXPERIMENTAL
Intervention: Electrical stimulation of the triceps surae muscles (NMES)
Number of subjects: 8
Study: 35069801

Group type: COMPARATOR
Intervention: Large-caliber endoscope (LCE)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Small-caliber endoscope (SCE)
Number of subjects: 45
Study: 33395182

Group type: EXPERIMENTAL
Intervention: Low-volume plyometric training (40-60 ground contacts per session, twice weekly) in HV-1 group
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Low-volume plyometric training (40-60 ground contacts per session, twice weekly) in VH-2 group
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no plyometric training)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Vertical plyometrics
Number of subjects: 32
Study: 35061525

Group type: EXPERIMENTAL
Intervention: Ultralow-risk patients (n = 1,000)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Low-risk patients (n = 3,295)
Number of subjects: 1000
Study: 34852839

Group type: EXPERIMENTAL
Intervention: Proactive telephone peer support intervention
Number of subjects: 693

Group type: EXPERIMENTAL
Intervention: First call support
Number of subjects: 693

Group type: EXPERIMENTAL
Intervention: Support at ≥12 weeks postpartum
Number of subjects: 693

Group type: EXPERIMENTAL
Intervention: Referrals during calls
Number of subjects: 693
Study: 35154343

Group type: EXPERIMENTAL
Intervention: Golden plaster
Number of subjects: 320

Group type: COMPARATOR
Intervention: Placebo plaster
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 320
Study: 33239100

Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitoring (CGM) with the Dexcom G6
Number of subjects: 72

Group type: COMPARATOR
Intervention: Finger-prick glucose monitoring (blinded CGM)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Real-time CGM
Number of subjects: 72

Group type: COMPARATOR
Intervention: Finger-prick glucose monitoring
Number of subjects: 72
Study: 33587781

Group type: EXPERIMENTAL
Intervention: Mouth Care Matters (MCM) program offered to all CNAs in NF-A
Number of subjects: 24

Group type: COMPARATOR
Intervention: Mouth Care Matters (MCM) program offered to 3 CNAs in NF-B
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no CNAs offered MCM program in NF-C)
Number of subjects: 24
Study: 36271441

Group type: EXPERIMENTAL
Intervention: Remote consent
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Remote site initiation visits (SIVs)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Remote data monitoring
Number of subjects: 156
Study: 32421171

Group type: EXPERIMENTAL
Intervention: Relaxation Response Resiliency Program for NF (3RP‐NF) via live videoconferencing
Number of subjects: 63

Group type: COMPARATOR
Intervention: Attention placebo control
Number of subjects: 63
Study: 36184472

Group type: EXPERIMENTAL
Intervention: Low tidal volume (LTV), pressure controlled ventilation (PCV), respiratory rate (RR) 20‐to‐30/min, peak inspiratory pressure adjusted to keep tidal volume (Vt) 2 mL/kg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP) of 5 cmH2O
Number of subjects: 120

Group type: COMPARATOR
Intervention: No mechanical ventilation (NOV)
Number of subjects: 120
Study: 32949078

Group type: EXPERIMENTAL
Intervention: 'Brown envelope' intervention for digital professionalism awareness training
Number of subjects: 11
Study: 35218867

Group type: EXPERIMENTAL
Intervention: Hydrus Microstent (HMS)
Number of subjects: 556

Group type: COMPARATOR
Intervention: Cataract Surgery (CS) only
Number of subjects: 556
Study: 32078145

Group type: EXPERIMENTAL
Intervention: HS016
Number of subjects: 648

Group type: COMPARATOR
Intervention: adalimumab
Number of subjects: 648
Study: 36344005

Group type: EXPERIMENTAL
Intervention: Liberal oxygen strategy (12-15 L O2/min or FiO2=0.6-1.0)
Number of subjects: 1420

Group type: COMPARATOR
Intervention: Restrictive oxygen strategy (>21% oxygen to ensure SpO2 of 94%)
Number of subjects: 1420
Study: 34226449

Group type: EXPERIMENTAL
Intervention: Clotrimazole 1% solution
Number of subjects: 102

Group type: COMPARATOR
Intervention: Econazole Nitrate 1% + Triamcinolone Acetonide 0.1% cream
Number of subjects: 102
Study: 32147926

Group type: EXPERIMENTAL
Intervention: Intention to treat (ITT) analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Per protocol (PP) analysis
Number of subjects: 0
Study: 32956782

Group type: EXPERIMENTAL
Intervention: HCQ/AZT combination
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: HCQ only
Number of subjects: 112

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 112
Study: 33896809

Group type: EXPERIMENTAL
Intervention: Sahrmann corrective exercises
Number of subjects: 30

Group type: COMPARATOR
Intervention: NASM corrective exercises
Number of subjects: 30
Study: 32169068

Group type: EXPERIMENTAL
Intervention: Small-incision cataract surgery in diabetic patients
Number of subjects: 59

Group type: COMPARATOR
Intervention: Small-incision cataract surgery in control patients
Number of subjects: 59
Study: 32572664

Group type: EXPERIMENTAL
Intervention: HIPEC plus adjuvant chemotherapy
Number of subjects: 352

Group type: COMPARATOR
Intervention: Conventional chemotherapy
Number of subjects: 352
Study: 32464799

Group type: EXPERIMENTAL
Intervention: Extracorporeal photopheresis plus standard immunosuppressive therapy (ECP)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard immunosuppressive therapy (CTR)
Number of subjects: 24
Study: 36096487

Group type: EXPERIMENTAL
Intervention: High intra-abdominal pressure (IAP) during HIPEC (>=18 mmHg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Low intra-abdominal pressure (IAP) during HIPEC (<18 mmHg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: High IAP during HIPEC
Number of subjects: 40

Group type: COMPARATOR
Intervention: Low IAP during HIPEC
Number of subjects: 40
Study: 34273733

Group type: EXPERIMENTAL
Intervention: Cloth facemask (CM)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Surgical facemask (SM)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No mask (NM)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cloth facemask (CM) and Surgical facemask (SM)
Number of subjects: 20
Study: 35616359

Group type: EXPERIMENTAL
Intervention: Integrity intervention program using moral integrity stories
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 200
Study: 33275962

Group type: EXPERIMENTAL
Intervention: US-guided SSNB using a proximal approach (n=23)
Number of subjects: 47

Group type: COMPARATOR
Intervention: US-guided SSNB using a distal approach (n=24)
Number of subjects: 47
Study: 33825723

Group type: EXPERIMENTAL
Intervention: Pletax® (cilostazol) 100 mg twice daily
Number of subjects: 100

Group type: COMPARATOR
Intervention: Trental® (pentoxifylline) 400 mg three times daily
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Pletax® (cilostazol)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Trental® (pentoxifylline)
Number of subjects: 100
Study: 36316067

Group type: EXPERIMENTAL
Intervention: Caregiver handwashing after handling animals
Number of subjects: 898

Group type: EXPERIMENTAL
Intervention: Caregiver handwashing before eating
Number of subjects: 898

Group type: EXPERIMENTAL
Intervention: Cohabitation with domestic animals
Number of subjects: 898

Group type: EXPERIMENTAL
Intervention: Living in a household with vinyl-covered dirt floors
Number of subjects: 898

Group type: EXPERIMENTAL
Intervention: Caregiver handwashing after child or self-defecation
Number of subjects: 898

Group type: EXPERIMENTAL
Intervention: Private latrine access
Number of subjects: 898

Group type: EXPERIMENTAL
Intervention: Shared sanitation access without handwashing
Number of subjects: 898
Study: 33909055

Group type: EXPERIMENTAL
Intervention: AI-based assistive tool
Number of subjects: 40
Study: 35468159

Group type: EXPERIMENTAL
Intervention: Conventional IVF
Number of subjects: 30

Group type: COMPARATOR
Intervention: ICSI
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Zygotes biopsied on day 5/6
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Blastocysts biopsied on day 5
Number of subjects: 30
Study: 34855311

Group type: EXPERIMENTAL
Intervention: H. psudoplicatum supplementation (250 mg/day for 6 weeks)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (250 mg/day for 6 weeks)
Number of subjects: 50
Study: 35172981

Group type: EXPERIMENTAL
Intervention: CALM (Managing Cancer and Living Meaningfully) therapy
Number of subjects: 195

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 195
Study: 32851435

Group type: EXPERIMENTAL
Intervention: Free Response Short Answer Questions (FRSAQs) test
Number of subjects: 109

Group type: COMPARATOR
Intervention: Traditional spot test
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: FRSAQs spot test
Number of subjects: 109

Group type: COMPARATOR
Intervention: FRSAQs vs Traditional spot test
Number of subjects: 109
Study: 35472303

Group type: EXPERIMENTAL
Intervention: Screening for AF using a 2-week single-lead electrocardiographic patch monitor
Number of subjects: 11931

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 11931
Study: 33034770

Group type: EXPERIMENTAL
Intervention: Endovascular coiling
Number of subjects: 73

Group type: COMPARATOR
Intervention: Microsurgical clipping
Number of subjects: 73
Study: 35420551

Group type: EXPERIMENTAL
Intervention: Estrogen-containing vaginal ring
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo vaginal ring
Number of subjects: 39
Study: 34097044

Group type: EXPERIMENTAL
Intervention: 1 dose of BNT162b2 vaccine
Number of subjects: 503875
Study: 34543417

Group type: EXPERIMENTAL
Intervention: Ledipasvir/Sofosbuvir treatment (12-week course)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Low adherence (taking <90% of doses)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: High adherence (taking ≥90% of doses)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Low adherence
Number of subjects: 144
Study: 35389391

Group type: EXPERIMENTAL
Intervention: n-6 PUFA-rich soybean oil (SO)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: MUFA-rich olive oil (OO)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: MUFA-rich camellia seed oil (CSO)
Number of subjects: 90
Study: 34292792

Group type: EXPERIMENTAL
Intervention: T300 + D (tremelimumab 300 mg plus durvalumab 1,500 mg followed by durvalumab 1,500 mg once every 4 weeks)
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Durvalumab monotherapy (1,500 mg once every 4 weeks)
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Tremelimumab monotherapy (750 mg once every 4 weeks for seven doses, then once every 12 weeks)
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: T75 + D (tremelimumab 75 mg once every 4 weeks plus durvalumab 1,500 mg once every 4 weeks for four doses, then durvalumab 1,500 mg once every 4 weeks)
Number of subjects: 332
Study: 35692047

Group type: EXPERIMENTAL
Intervention: CETEG (lomustine and temozolomide) followed by partial brain radiotherapy (RT) plus PCV (RT-PCV) at progression
Number of subjects: 182

Group type: COMPARATOR
Intervention: Partial brain radiotherapy (RT) followed by procarbazine, lomustine, and vincristine (PCV) chemotherapy (RT-PCV)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Best investigators choice (BIC) at progression
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: CETEG (lomustine and temozolomide)
Number of subjects: 182

Group type: COMPARATOR
Intervention: RT-PCV
Number of subjects: 182
Study: 33421091

Group type: EXPERIMENTAL
Intervention: TCu380A IUD
Number of subjects: 140

Group type: COMPARATOR
Intervention: LNG IUS
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Vaginal delivery
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Cesarean delivery
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Post-placental IUD insertion
Number of subjects: 140
Study: 34494357

Group type: EXPERIMENTAL
Intervention: Metacognitive Remediation Therapy (MCR)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control (non-participation in MCR)
Number of subjects: 73
Study: 34256958

Group type: EXPERIMENTAL
Intervention: Socket Shield Technique (SST)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Minimally Traumatic Extraction Approach
Number of subjects: 27
Study: 35587680

Group type: EXPERIMENTAL
Intervention: Modified comfortable nursing
Number of subjects: 128

Group type: COMPARATOR
Intervention: Conventional four‐handed operation nursing
Number of subjects: 128
Study: 35025539

Group type: EXPERIMENTAL
Intervention: Supportive-Expressive Therapy (SET)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Supportive Therapy (ST)
Number of subjects: 100
Study: 34962514

Group type: EXPERIMENTAL
Intervention: Care coordination with an Allied Health Liaison Officer
Number of subjects: 81

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 81
Study: 34087060

Group type: EXPERIMENTAL
Intervention: Physicians' diabetes self-management education using Japan Association of Diabetes Education and Care education tool and SMBG analyzer
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (no use of Japan Association of Diabetes Education and Care education tool and SMBG analyzer)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 76
Study: 32924560

Group type: EXPERIMENTAL
Intervention: Reflexology
Number of subjects: 88

Group type: COMPARATOR
Intervention: Relaxation
Number of subjects: 88
Study: 35485657

Group type: COMPARATOR
Intervention: Training on a stabiloplatform with biofeedback (BFB)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Vestibular gymnastics
Number of subjects: 40
Study: 35291853

Group type: EXPERIMENTAL
Intervention: Simulation education
Number of subjects: 77

Group type: COMPARATOR
Intervention: Written education
Number of subjects: 77
Study: 34404446

Group type: EXPERIMENTAL
Intervention: Combined physical and internet‐delivered psychological intervention (psychologically informed physical treatments)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 25
Study: 32453835

Group type: EXPERIMENTAL
Intervention: 2 × 1.5 h psychoeducation intervention and a set of booklets
Number of subjects: 215

Group type: COMPARATOR
Intervention: Set of booklets only
Number of subjects: 215
Study: 35523955

Group type: EXPERIMENTAL
Intervention: Intensive Lifestyle Intervention (ILI)
Number of subjects: 577

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 577
Study: 34273498

Group type: EXPERIMENTAL
Intervention: Add-on dry powder inhalation (DPI) of combined anti-TB therapy (isoniazid 5 mg, rifampicin 2 mg, pyrazinamide 16 mg, levofloxacin 2 mg)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Add-on dry powder inhalation (DPI) of combined anti-TB therapy
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo DPI
Number of subjects: 91
Study: 36217134

Group type: EXPERIMENTAL
Intervention: Pendulum appliance
Number of subjects: 40

Group type: COMPARATOR
Intervention: Clear Aligners
Number of subjects: 40
Study: 34684591

Group type: EXPERIMENTAL
Intervention: ONS1 + DC
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: ONS2 + DC
Number of subjects: 321

Group type: COMPARATOR
Intervention: DC only
Number of subjects: 321
Study: 33213541

Group type: COMPARATOR
Intervention: Sertraline (SSRI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bupropion (NDRI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34339684

Group type: EXPERIMENTAL
Intervention: Bilevel positive airway pressure with backup rate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Home mechanical ventilators
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proposed recommendations for noninvasive ventilation access
Number of subjects: 0